Invention Grant
- Patent Title: Heterocyclic compounds and methods of use thereof
-
Application No.: US15187656Application Date: 2016-06-20
-
Publication No.: US09938261B2Publication Date: 2018-04-10
- Inventor: Michael J. Hadd , Michael D. Hocker , Mark W. Holladay , Gang Liu , Martin W. Rowbottom , Shimin Xu
- Applicant: AMBIT BIOSCIENCES CORPORATION
- Applicant Address: US CA San Diego
- Assignee: Ambit Biosciences Corporation
- Current Assignee: Ambit Biosciences Corporation
- Current Assignee Address: US CA San Diego
- Agency: Jones Day
- Main IPC: A61K31/535
- IPC: A61K31/535 ; C07D417/06 ; C07D413/14 ; C07D413/06 ; C07D417/14 ; C07D471/04 ; C07D487/04 ; A61K31/422 ; A61K31/427 ; A61K31/437 ; A61K31/4439 ; A61K31/454 ; A61K31/52 ; A61K31/5377 ; A61K45/06
Abstract:
Provided herein are heterocyclic compounds for treatment of CSF1R, FLT3, KIT, and/or PDGFRβ kinase mediated diseases. Also provided are pharmaceutical compositions comprising the compounds and methods of using the compounds and compositions.
Public/Granted literature
- US20160362405A1 HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF Public/Granted day:2016-12-15
Information query
